Clinical Trial Update: OPT101 in Patients With Community Acquired Pneumonia (CAP) With Sepsis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for OPT101 in patients with community-acquired pneumonia and sepsis; the study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia
• Sepsis

Drugs mentioned

• OPT101

Snippet

Sponsor: Op-T LLC | Conditions: Sepsis, Community Acquired Pneumonia (CAP) | Phase 1 | Status: NOT_YET_RECRUITING